Shares of NatWest Group plc (LON:NWG – Get Rating) have been given a consensus recommendation of “Buy” by the eleven ratings firms that are covering the firm, Marketbeat Ratings reports. One investment analyst has rated the stock with a hold rating and ten have assigned a buy rating to the company. The average 12 month price target among brokers that have issued ratings on the stock in the last year is GBX 302.50 ($3.94).
A number of research analysts have recently issued reports on NWG shares. Berenberg Bank restated a “buy” rating and issued a GBX 300 ($3.90) price target on shares of NatWest Group in a research report on Tuesday, March 1st. Morgan Stanley reissued an “overweight” rating on shares of NatWest Group in a research note on Wednesday, March 9th. Royal Bank of Canada reissued an “outperform” rating and set a GBX 270 ($3.51) target price on shares of NatWest Group in a research note on Wednesday, March 30th. Deutsche Bank Aktiengesellschaft reissued a “buy” rating and set a GBX 300 ($3.90) target price on shares of NatWest Group in a research note on Monday, February 21st. Finally, Barclays reaffirmed an “overweight” rating and issued a GBX 320 ($4.16) price objective on shares of NatWest Group in a research note on Wednesday.
LON NWG opened at GBX 225.90 ($2.94) on Thursday. NatWest Group has a 12 month low of GBX 182.85 ($2.38) and a 12 month high of GBX 258.10 ($3.36). The company has a market capitalization of £23.99 billion and a price-to-earnings ratio of 8.93. The company’s fifty day moving average price is GBX 221.18 and its two-hundred day moving average price is GBX 226.21.
NatWest Group Company Profile (Get Rating)
NatWest Group plc, together with its subsidiaries, provides banking and financial products and services to personal, commercial, corporate, and institutional customers in the United Kingdom and internationally. It operates through Retail Banking, Commercial Banking, Private Banking, RBS International, and NatWest Markets segments.
Recommended Stories
- Google Upgraded Ahead Of Earnings
- Highly Valued Abbot Laboratories Could Move Lower
- Baker Hughes, Another Buy-The-Dip Opportunity In Oilfield Services
- Netflix (NASDAQ: NFLX) Falls Back to 2018 Levels
- Is Turning Point Therapeutics Stock at a Turning Point?
Receive News & Ratings for NatWest Group Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for NatWest Group and related companies with MarketBeat.com's FREE daily email newsletter.